Vanguard Personalized Indexing Management
IONS icon

Vanguard Personalized Indexing Management’s Ionis Pharmaceuticals IONS Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$946K Buy
11,933
+519
+5% +$39.1K 0.01% 1032
2026
Q1 		$857K Sell
11,414
-1,047
-8% -$82.6K 0.01% 1006
2025
Q4 		$986K Buy
12,461
+371
+3% +$27.9K 0.01% 918
2025
Q3 		$791K Buy
12,090
+18
+0.1% +$879 0.01% 1023
2025
Q2 		$477K Buy
12,072
+1,759
+17% +$57.6K 0.01% 1216
2025
Q1 		$311K Sell
10,313
-1,958
-16% -$64.1K ﹤0.01% 1324
2024
Q4 		$429K Buy
12,271
+3,867
+46% +$145K 0.01% 1190
2024
Q3 		$337K Buy
8,404
+780
+10% +$36.3K 0.01% 1288
2024
Q2 		$363K Buy
7,624
+261
+4% +$10.7K 0.01% 1181
2024
Q1 		$319K Sell
7,363
-979
-12% -$46.7K 0.01% 1240
2023
Q4 		$422K Buy
8,342
+1,564
+23% +$74.9K 0.01% 1085
2023
Q3 		$307K Sell
6,778
-389
-5% -$16K 0.01% 1115
2023
Q2 		$294K Buy
7,167
+1,301
+22% +$50K 0.01% 1142
2023
Q1 		$210K Sell
5,866
-293
-5% -$11K 0.01% 1314
2022
Q4 		$233K Buy
6,159
+950
+18% +$40K 0.01% 1075
2022
Q3 		$230K Sell
5,209
-874
-14% -$36.8K 0.01% 1057
2022
Q2 		$225K Buy
6,083
+487
+9% +$18.4K 0.01% 1099
2022
Q1 		$207K Buy
+5,596
New +$183K 0.01% 1112
2021
Q4 		– Sell
-13,544
Closed -$454K – 1084
2021
Q3 		$454K Buy
+13,544
New +$510K 0.04% 569

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Personalized Indexing Management's IONS Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Ionis Pharmaceuticals (IONS) stake by 4.5% in Q2 2026, buying an estimated $39.1K and bringing the position to 11,933 shares worth $946K. The position accounts for 0.01% of the portfolio, ranked #1032.

Vanguard Personalized Indexing Management first reported a position in IONS in Q3 2021 and has held it in 19 quarters since. The position peaked at $986K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,933 shares of Ionis Pharmaceuticals worth $946K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 519 Ionis Pharmaceuticals shares in Q2 2026, an estimated $39.1K.
  • Ionis Pharmaceuticals made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1032 holding.
  • Vanguard Personalized Indexing Management first reported a position in Ionis Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Vanguard Personalized Indexing Management's Ionis Pharmaceuticals position peaked at $986K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.